Abstract
Endometrial cancer remains the only gynecologic malignancy with a rising incidence and mortality. Although diagnostic techniques have evolved modestly, the surgical management of endometrial cancer was transformed with incorporation of sentinel lymph node dissection paradigms. Furthermore, significant gains have been achieved in molecular characterization of endometrial cancer, with publication of The Cancer Genome Atlas (TCGA) endometrial and subsequent studies. Incorporation of molecular diagnostics has ushered in immunotherapy as an effective treatment strategy in select patients, with alternate targeted therapies emerging as promising options.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
